Serum HLA class I soluble antigens: a marker of acute rejection following liver transplantation. 1995

E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
Divisione Trapianti d'Organo, Università di Roma La Sapienza, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
July 1994, Human immunology,
E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
June 1985, The Tokai journal of experimental and clinical medicine,
E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
January 1997, Transplantation proceedings,
E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
December 1997, Human immunology,
E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
January 1995, American journal of nephrology,
E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
March 1992, Journal of hepatology,
E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
February 2006, Annals of the rheumatic diseases,
E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
January 2000, Medical science monitor : international medical journal of experimental and clinical research,
E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
May 1999, Human immunology,
E Renna Molajoni, and F Puppo, and S Brenci, and M Scudeletti, and P Cinti, and D Alfani, and F Indiveri, and R Cortesini
November 1999, Zhonghua wai ke za zhi [Chinese journal of surgery],
Copied contents to your clipboard!